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Background: Spotted Fever Group (SFG) Rickettsiae can cause febrile diseases with or without rash in humans
worldwide. In Germany only limited data are available about their medical significance. Serological screening tests
for antibodies against rickettsiae usually only distinguish between SFG and Typhus Group (TG) Rickettsiae due to
the strong cross reactivities within the groups. Seroprevalence rates in dogs, as possible sentinels for tick-borne
diseases, could serve as an indicator for the distribution of different Rickettsia species.
Methods: In this study, a micro-immunofluorescence assay (micro-IFA) was established for detection and
differentiation of antibodies against five Rickettsia species in dogs (R. helvetica, R. raoultii, R. slovaca, R. monacensis
and R. felis). Dogs that never left Germany (n = 605) previously investigated with an SFG-ELISA were included in this
study and screened at a 1:128 dilution. Endpoint titres of fifty randomly selected seropositive samples of each of
the five investigated regions in Germany were determined in order to allow a differentiation of the causative
Rickettsia species. Sensitivity and specificity of the micro-IFA were compared with ELISA results of the previous study.
Results: A total of 93.9% of the dogs were positive for antibodies of the SFG Rickettsiae at the screening titer of 1:128.
Differentiation of SFG Rickettsiae with the micro-IFA was possible in 70.4%, but in 29.6% of the cases the detected
antibodies were not differentiable. Considering a clear differentiation by a twofold titre difference between observed
reactions, the seroprevalence rates were 66.0% for R. helvetica, 2.8% for R. raoultii, 1.6% for R. slovaca, but no serological
reaction could be clearly attributed to R. monacensis or R. felis. No statistically significant regional differences were found
for R. helvetica, R. slovaca and R. raoultii comparing the five regions of Germany. Comparison of micro-IFA with ELISA
revealed a sensitivity of 82.0% and a specificity of 83.8% for the Rickettsia SFG ELISA.
Conclusions: The micro-IFA is a useful serological tool to differentiate antibodies against different Rickettsia species in
dogs. Seroprevalence rates in dogs correspond to the prevalence rates and distribution of Rickettsia-carrying tick
species.
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Rickettsiae are short rod-shaped gram-negative, obligate
intracellular bacteria [1]. They are, regarding the clinical
and serological perspective, divided into two major
groups: the Typhus Group (TG) and the Spotted Fever
Group (SFG). The TG includes two members: R. typhi
and R. prowazekii, the causative agents of murine typhus
and epidemic typhus, respectively. The heterogeneous
SFG contains >20 Rickettsiae, mainly transmitted by
ticks, except for R. felis which is transmitted by fleas and
R. akari which is transmitted by mites [2-4]. Recent gen-
omic analyses indicate the divison into four groups: the
TG, the SFG, the ancestral group (AG) and the transi-
tional group (TRG), which includes R. felis [5]. Rickett-
siae of the SFG are able to cause mild to severe
rickettsioses in humans [6]. Rickettsioses are considered
emerging infectious diseases worldwide [1,7]. To evalu-
ate the epidemiological situation in different countries it
is necessary to examine vectors and reservoir hosts for
the occurrence of different rickettsial species. Various
molecular and serological methods have been described
for the detection and differentiation of Rickettsia species.
Real-time polymerase chain reaction (PCR) is frequently
applied to detect Rickettsia in biopsies, blood andTable 1 Prevalence rates of Spotted Fever Group Rickettsiae
Rickettsia species Tick species % pos Nu











R. raoultii Dermacentor 30.0% 66
spp. 56.7% 13
R. slovaca Dermacentor 0.8% 66
spp. 13.3% 15





R. felis I. ricinus 0.4% 14
R. massiliae I. ricinus 1.7% 57
BE: Berlin; BY: Bavaria; BW: Baden-Wurttemberg; NI: Lower Saxony; NRW: North Rhinarthropods [7]. Several conventional PCRs targeting dif-
ferent genomic regions for subsequent sequencing and
phylogenetic analysis of rickettsiae have been published
in the last decades [4,8,9]. Species-specific real-time
PCRs are only available for some rickettsial species (e.g.
R. conorii, R. rickettsii) [10,11]. Due to the strong sero-
logical cross-reactions among SFG Rickettsiae, the avail-
ability of serological tools for differentiation is limited,
so far. Commercially available IFA and ELISA tests are
only suitable for the discrimination between SFG- and
TG-Rickettsiae [1]. Brouqui et al. [12] described a
micro-immunofluorescence method which allows the in-
vestigation of up to nine different rickettsial antigens in
one spot as a suitable method to differentiate the causa-
tive Rickettsia species by determination of endpoint ti-
tres. Absorption western blotting can also be used to
identify rickettsial species [13]. The rickettsial IFA
adapted to the micro-method format (micro-IFA) is the
test of choice for the serodiagnosis of rickettsial disease
in human medicine [1]. In Germany, six species of the
SFG Rickettsiae have been detected in ticks by molecular
methods (Table 1). All of them have been described to
cause diseases in humans. R. helvetica is generally asso-
ciated with uneruptive fever, but cases with more severein ticks in Germany, according to the geographic region
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been reported [14-16]. R. monacensis, R. massiliae and
R. felis can cause classical spotted fevers and additional
constitutional symptoms like fatigue, headache and my-
algia [7,17-23]. Nevertheless the pathogenicity of R. felis
is still discussed controversially [24]. R. raoultii and R.
slovaca cause TIBOLA (tick-borne lymphadenopathy)
or DEBONEL (Dermacentor-borne necrosis erythema
lymphadenopathy) with a typical clinical syndrome includ-
ing an eschar at the site of the tick bite and lymphadenop-
athy [25-27]. Data concerning clinical human cases in
Germany are rare. In the recent years only a few cases
have been published, among them cases of R. slovaca in-
fection in 2009 and one in 2010 [27,28] and a case of R.
felis infection in 2000 [29]. So far no clinical cases caused
by R. monacensis, R. helvetica, R. massiliae or R. raoultii
were described in Germany. In 2008, 9.1% of 256 exam-
ined hunters in Germany had antibodies against the SFG
Rickettsiae in an IFA [30]. In 2012, an average of 27.7% of
forestry workers had antibodies against the SFG Rickett-
siae in the IFA with seroprevalences up to 55% in particu-
lar geographical regions (Wölfel et al., Seroprevalence of
IgG against Rickettsiae of the Spotted Fever Group in For-
estry Workers in State Brandenburg, Eastern Germany,
unpublished). In 2014, we detected antibodies against the
SFG Rickettsiae in 77.9% of 605 dogs examined with
ELISA (Wächter et al., Seroprevalence of Spotted Fever
Group Rickettsiae in dogs in Germany, in press). Until
now no clinical cases in dogs involving the rickettsial spe-
cies R. helvetica, R. raoultii, R. slovaca, R. massiliae, R. felis
or R. monacensis have been reported. However, R. rickett-
sii in the USA and R. conorii in southern Europe can cause
symptomatic diseases of variable severity in dogs [31,32].
Rickettsia rickettsii causes a severe vasculitis leading to
symptoms like lethargy, anemia and neurologic symptoms
[31]. Rickettsia conorii, causing the Mediterranean Spotted
Fever in humans, can lead to symptoms like fever, diar-
rhea, vomiting and petechial rash in dogs [32]. In our pre-
vious study statistically significant correlations between
age, tick infestation and seropositivity of the dogs were
found, but no differentiation of rickettsial species was pos-
sible by ELISA (Wächter et al., Seroprevalence of Spotted
Fever Group Rickettsiae in dogs in Germany, in press).
Therefore, the aims of the study were (i) to establish the
micro-IFA as a tool to distinguish antibodies against dif-
ferent rickettsial species in dogs (ii) to differentiate the
antibody responses in dogs previously found positive by
ELISA and (iii) to compare the micro-IFA to a commercial
ELISA with regard to sensitivity and specificity.
Methods
Samples
Altogether 605 serum samples of dogs from a previous
study (Wächter et al., Seroprevalence of Spotted FeverGroup Rickettsiae in dogs in Germany, in press) were
tested for antibodies against five SFG Rickettsiae by
micro-IFA. These samples had previously been tested for
antibodies against SFG Rickettsiae by a commercial
ELISA (Canine Spotted Fever Rickettsia EIA IgG Anti-
body Kit, Fuller Laboratories, Fullerton, California, USA)
(Wächter et al., Seroprevalence of Spotted Fever Group
Rickettsiae in dogs in Germany, in press). Dogs included
in this study were (i) born in Germany, (ii) had never left
Germany and (iii) data on sex, age, breed, location, clin-
ical status (healthy or sick), tick infestation and date of
blood collection were available.
Production of micro-IFA-slides
Rickettsia helvetica strain AS 819, R. raoultii strain Kha-
barovsk (kindly provided by Lee Fuller, Fuller Laborator-
ies), R. slovaca strain RU 828, R. monacensis strain AS
787 and R. felis strain ELB (kindly provided by Lee
Fuller, Fuller Laboratories) were cultivated in 75 cm2 tis-
sue culture flasks containing either Vero cells or Dros-
ophila melanogaster cells (only R. felis). Readily infected
cell cultures were harvested after 8 to 19 days, depend-
ing on the growth characteristics of the respective Rick-
ettsia species. Identity and purity of the strains was
confirmed by sequencing a part of the ompB gene fol-
lowing a protocol of Roux and Raoult [2]. After inactiva-
tion by adding formalin in a final concentration of 1%
the Rickettsiae were released from their host cells by
needle disruption. The suspension was centrifuged twice
at 1,000 g, 4°C for 5 minutes to remove cell debris. The
supernatant was collected. Centrifugation at 17,000 g,
4°C for 5 minutes followed twice. Every time the super-
natant was discarded and the pellet was resuspended in
1.8 ml phosphate buffered saline (PBS). The final pellet
was resuspended in 100 μl PBS. Serial dilutions in PBS
(1:2, 1:5, 1:10) of the antigens were applied with a 10 μl
piston-operated pipette to empty slides to estimate the
density of rickettsial antigen by IFA and Diff-Quick ®
(Polysciences, Warrington, USA) staining to equalize the
density of all five rickettsial species. R. felis, R. monacen-
sis and R. slovaca were diluted with PBS 1:10, R. helve-
tica and R. raoultii were used as undiluted solutions.
The different rickettsial antigens were applied to a 10-well
microscope slide with a pen-point as shown in Figure 1.
The slides were air dried and fixed in methanol-acetone
(1:1) for 30 min, air-dried again and stored at 4°C
until use.
Micro-IFA
A twofold serial dilution of the serum samples with PBS
was made and the screening dilution of 1:128 was ap-
plied to the slide wells and incubated at 37°C for 45 min
in a humid chamber. The slide was washed with 0.2%
PBS-Tween (Euroimmun, Lübeck, Germany) three times
Figure 1 Arrangement of rickettsial antigen dots per spot on
the Micro IFA-Slide.
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rabbit anti-dog immunoglobulin G (Sigma-Aldrich, St.
Louis, USA) was applied in a 1:20 dilution and incubated
at 37°C for 30 min in a humid chamber, washed with
0.2% PBS-Tween three times for 5 min and mounted
with fluorescence mounting medium (Dako, Carpinteria,
California, USA). Reactions were read with a fluores-
cence microscope (Leica 5000, Wetzlar, Germany) by
two independent investigators. Suitable positive and
negative control dog sera that had been identified in a
previous study (Wächter et al., Seroprevalence of Spot-
ted Fever Group Rickettsiae in dogs in Germany, in
press) were included in each assay. Samples were consid-
ered positive for antibodies of the SFG Rickettsiae when
any of the five antigens showed distinct fluorescence pat-
terns at the 1:128 dilution (Figure 2). Fifty positive sam-
ples of each of the five regions (Figure 1) were chosen
with a random generator (source: http://rechneronline.
de/zufallszahlen/, 20-05-2014) and subjected to end-
point titration. If one rickettsial species showed at least
twofold higher antibody titres than the others, it wasFigure 2 Positive reaction for antibodies against Rickettsia
raoultii antigen on the Micro IFA-Slide (dilution 1:128).considered the species responsible for the antibody in-
duction. If more than one species showed fluorescence
at the same end point titre the results were considered
not distinguishable.
Comparison ELISA-micro-IFA
The results of the screening dilution (1:128, n = 605) of
this study obtained with micro-IFA were compared to
results obtained with ELISA from a previous study
(Wächter et al., Seroprevalence of Spotted Fever Group
Rickettsiae in dogs in Germany, in press).
Statistical analysis
Statistical analysis was performed with SPSS® version
21.0.1., SPSS Inc., Chicago, IL, USA. Correlations be-
tween location and seropositivity were compared by χ2-
test, for small sample sizes the Fishers exact test was
used. Statistical significance was considered at a p-value
<0.05. Multiple comparisons were corrected with the
Bonferroni adjustment to p < 0.01. Confidence intervals
(95% CI) were calculated individually for each propor-
tion with the Clopper and Pearson method. Sensitivity
and specificity of the ELISA was calculated as follows:
Sensitivity (true positive rate = TPR) = TP (true positive)/
P (positive) and specificity (SPC, true negative rate) =
TN (true negative)/ N (negative). The TP and the TN
were the sera seropositive and seronegative for anti-
bodies for the SFG tested with the micro-IFA, P and N
were the sera tested seropositive and seronegative with
the ELISA, respectively.
Results
At the screening serum dilution of 1:128, 568 out of 605
(93.9%; CI: 91.7%-95.7%) of the dogs showed antibodies
against at least one of the SFG Rickettsiae. Out of the
93.9% anti-Rickettsia positive dog specimens 70.4%
showed at least twofold higher antibody titres against
one Rickettsia species and were therefore considered as
clearly differentiable. In 23.6% of the dogs equal anti-
body titers against two and in 5.6% against three rick-
ettsial antigens were observed. Only one specimen
(0.4%) was reactive against four of the five Rickettsia
species (Table 2). All of those were considered as non-
differentiable with regard to the antibody-inducing
Rickettsia species. Considering only the 70.4% clearly
differentiable serum samples the total seroprevalence
rates were 66.0% (CI: 59.8%-71.9%) for R. helvetica,
2.8% (CI: 1.1%-5.7%) for R. raoultii, 1.6% (CI: 0.4%-4.1%)
for R. slovaca, 0.0% (CI: 0.0%-0.1%) for R. monacensis and
0.0% (CI: 0.0%-0.1%) for R. felis. If all positive serological
reactions against the tested rickettsial species, including
cross-reactive antibodies, in the randomly selected 250
positive sera (50 from each of the five regions in Germany)
were considered, 94.0% (CI: 90.3%-96.6%) for R. helvetica,
Table 2 Seropositivity for SFG Rickettsiae of the dogs with regard to number and association of the different
rickettsial species
Number of rickettsial species with
seropositivity in dogs
Rickettsial species No. of positive animals (%)
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SFG: Spotted fever group.
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8.7%) for R. slovaca, 2.0% (CI: 0.7%-4.6%) for R. monacen-
sis and 0.4% (CI: 0.0%-0.2%) for R. felis could be observed.
Titres varied for R. helvetica from 1:128 to 1:4096, for R.
raoultii from 1:128 to 1:4096, for R. slovaca from 1:256 to
1:2048, for R. monacensis from 1:256 to 1:2048 and for R.
felis from 1:128 to 1:512 (Table 3). No statistically signifi-
cant different infection rates for R. helvetica (p = 0.038), R.
slovaca (p = 0.105) and R. raoultii (p = 0.131) were ob-
served comparing the five different regions of Germany
(Figure 3). Statistically significant differences for R. helve-
tica were seen comparing north and south (p = 0.042),
south and middle (p = 0.042) and south and west (p =
0.007). Comparison of ELISA (Wächter et al., Seropreva-
lence of Spotted Fever Group Rickettsiae in dogs in
Germany, in press) and micro-IFA yielded the following
results. All serum samples (n = 605) were tested at a cut-
off titre of 1:128. With the ELISA 77.6% (CI: 74.1%-80.9%)of the samples were positive, whereas with the micro-IFA
93.9% (CI: 91.7%-95.7%). Altogether 102 samples were
tested positive in the micro-IFA and negative in the ELISA
and 6 samples were tested positive in the ELISA and nega-
tive in the micro-IFA. Considering this data at a cut-off
titre of 1:128 the ELISA shows a sensitivity of 82.0% and a
specificity of 83.8%.
Discussion
Our study presents the first findings about serological
differentiation of rickettsial species in dogs in Germany.
The serological differentiation of antibodies against SFG
Rickettsiae is difficult due to their strong cross reactivity
[12]. The micro-IFA method has already been used
by several authors to differentiate between antibodies
against SFG-Rickettsiae. Breitschwerdt et al. [44] used
micro-IFA for a seroepidemiological study in dogs test-
ing for R. rickettsii, R. rhipicephali, R. montana and R.
Table 3 Seropositivity for 50 sera/region for R. helvetica, R. raoultii, R. slovaca, R. monacensis and R. felis in serum samples of dogs tested at serial dilutions
Rickettsial
species
RH RR RS RM RF
No seropositive (%) No seropositive (%) No seropositive (%) No seropositive (%) No seropositive (%)
Titre Differentiable Not differentiable Differentiable Not differentiable Differentiable Not differentiable Differentiable Not differentiable Differentiable Not differentiable
1:128 1 (0.6%) 2 (2.9%) 5 (71.4%) 2 (4.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 1 (100.0%)
1:256 10 (6.1%) 5 (7.1%) 1 (14.3%) 3 (6.0%) 0 (0.0%) 1 (11.1%) 0 (0.0%) 1 (20.0%) 0 (0.0%) 0 (0.0%)
1:512 36 (21.8%) 12 (17.1%) 0 (0.0%) 9 (18.0%) 2 (50.0%) 2 (22.2%) 0 (0.0%) 1 (20.0%) 0 (0.0%) 0 (0.0%)
1:1024 86 (52.1%) 29 (41.4%) 0 (0.0%) 23 (46.0%) 1 (25.0%) 5 (55.5%) 0 (0.0%) 1 (20.0%) 0 (0.0%) 0 (0.0%)
1:2048 12 (7.3%) 9 (12.9%) 1 (14.3%) 6 (12.0%) 1 (25.0%) 1 (11.1%) 0 (0.0%) 2 (40.0%) 0 (0.0%) 0 (0.0%)
1:4096 20 (12.1%) 13 (18.6%) 0 (0.0%) 7 (14.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)

















Figure 3 Division of Germany for sample assessment in five regions and seroprevalence rates of the tested Rickettsia spp. based on
the 50 positive samples tested in the five different regions.
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were investigated in hunters to differentiate antibodies
against indigenous German SFG Rickettsiae as well as
species endemic in regions were the hunters had trav-
elled before [30]. The use of a micro-IFA method en-
ables to a certain extent the differentiation of the
antibodies leading to the most dominant serological re-
sponse. However, a prerequisite is the knowledge of
which Rickettsiae occur in the investigated region [45].
We included antigens of SFG Rickettsiae that have been
repeatedly detected in Germany and have been described
to cause clinical manifestations. R. massiliae was not
used because a single detection exclusively by molecular
tools in Germany was described so far (Table 1) [7]. In
this study we examined dogs as potential hosts for the
Rickettsia species previously described in Germany and
showed that, to a certain extent, it is serologically pos-
sible to distinguish between them. In 29.6% of the cases
the detected antibodies were not differentiable and thus
did not allow a clear species allocation. Some authors
state that if two or more rickettsial species show distinct
fluorescence at the end-titre they may be co-infectious
rickettsial species [44,46]. As dogs are more frequently
exposed and infested with ticks and the pathogens they
harbor than humans, dogs might likely be infected with
more than one Rickettsia species sequentially during
their lifetime, thus explaining the high percentage of notdistinguishable seropositive animals (Wächter et al.,
Seroprevalence of Spotted Fever Group Rickettsiae in
dogs in Germany, in press). For the major part (66%) of
the samples at least twofold higher antibody titres
against R. helvetica could be observed. These findings
are consistent with the fact that the vector for R. helve-
tica is Ixodes ricinus, the most abundant tick species in
Germany. Prevalence rates of R. helvetica in I. ricinus
ticks were found in Bavaria, Baden-Wurttemberg, Berlin,
Saarland, Lower Saxony and Saxony ranging from 3.5%
up to 52.5% (Table 1). The lowest prevalence rates in
ticks were found in southern Germany. Accordingly, the
lowest seroprevalence rate was found in dogs originating
from there. The highest prevalence rates were found in
Lower Saxony, which is partly identical with the middle
and northern region of Germany where high seropreva-
lence rates in dogs were found [7,38], (Table 3). Regard-
ing the distribution of dogs with antibodies against R.
raoultii and R. slovaca the distribution areas of the vec-
tors have to be considered. So far, in Germany R. raoultii
has only been detected in Dermacentor reticulatus, R.
slovaca only in D. marginatus [28,39]. Spitalska et al.
[47] described in the Slovak Republic that D. marginatus
and D. reticulatus could also be host for R. raoultii and
R. slovaca, respectively. However, comparing the geo-
graphic distribution in Germany for D. reticulatus and
D. marginatus [48] with the distribution of seropositive
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seroprevalence comparing the different regions is not
statistically significant may be due to the fact that the
number of cases were very small (Table 3). R. monacen-
sis was detected in low prevalences in ticks (0.2%-0.6%)
nearly exclusively in Bavaria, only one study reported R.
monacensis in ticks in Lower Saxony (Table 1). Regard-
ing the dogs with cross-reactive antibodies against R.
monacensis, these five dogs were nearly all located in the
south of Germany. When comparing the vectors and
their infection rates of I. ricinus for R. helvetica (3.5%-
52.5%) and of the cat flea Ctenocephalides felis for R.
felis (25.0%-56.0%) it may be surprising that the sero-
prevalence rate in dogs for R. helvetica is 66.0% and for
R. felis is 0.0%. However, looking at the infestation of
dogs with their vectors, a study about population dy-
namics of fleas in Germany showed that just 5.1% of the
dogs are infested with fleas [49,50]. We showed in our
previous study that 91.1% of the examined dogs were
infested with ticks up to five ticks/month, and 17.5%
even up to 20 ticks/month (Wächter et al., Seropreva-
lence of Spotted Fever Group Rickettsiae in dogs in
Germany, in press). Therefore infestation rates with ticks
seem higher than with fleas which may lead to higher
seroprevalence rates of R. helvetica compared to R. felis
although the infection rates in the vector population are
approximately even (Table 1), [50]. There were no dogs
with antibodies exclusively against R. felis. The cross-
reaction of R. felis with other members of the SFG is dis-
cussed controversially in the literature. The antibodies
have been reported to show stronger reactivity to R.
typhi from the Typhus Group than to members of the
Spotted Fever Group [22,51-53]. Fang and Raoult [54]
described that mouse polyclonal antisera against R. felis
only cross-reacted to members of the SFG Rickettsiae
but not to the TG. However, in contrast to the study of
Fang and Raoult [54], serum of a classical human case of
murine typhus showed exclusive reactivity with TG-
Rickettsiae and R. felis antigen but none with SFG-
Rickettsiae. The same results were obtained when testing
a commercially available positive anti-TG Rickettsia
positive control (Fuller Laboratories, Fullerton, California,
USA) (Wölfel et al., personal communication). In sum-
mary this indicates that R. felis might be the only SFG
Rickettsia to show antigenic relation to the TG Rickett-
siae, but can show reactivity to other SFG Rickettsia as
well [55]. R. felis was the only antigen for which titres
above 1:512 were not observed. However, it remains
unclear, if the reactivity against several rickettsial anti-
gens including R. felis was caused by multiple infections
or by cross reaction. The serologic test systems micro-
IFA and ELISA are used for seroepidemiologic surveys
as well as diagnosing acute cases. The micro-IFA is the
gold standard in human medicine, its sensitivity isindicated with over 97%, its specificity with over 99% if
a dilution of 1:64 or higher is used [7]. Clements et al.
[56] compared the two test systems for diagnosing
Rocky Mountain Spotted Fever in humans and in this
study the ELISA was as sensitive and as specific as the
IFA. Compared to the adapted micro-IFA test in this
study the ELISA of the previous study had a moderate
sensitivity (82.0%) and specificity (83.8%). These results
are in line with non-published results of a comparable
study with human sera. In that study, titres lower than
1:128 in an IFA could not be detected by ELISA
(Dobler et al., personal communication). One reason
for this reduced sensitivity might be that ELISA systems
usually are designed for the clinical diagnosis of acute
infections with high antibody titres instead of epidemio-
logical studies (Dobler et al., personal communication).
Lower antibody titres as expected after a longer post infec-
tion interval therefore might remain undetected by ELISA.
The sensitivity of a serological assay also depends on the
used antigen. In this case the ELISA used in the previous
study was produced with R. rickettsii antigen, the causative
agent of RMSF. Lower sensitivity and specificity rates for
antibodies against other rickettsial species might be ex-
plained by that, as this Rickettsia species is not endemic in
Germany. If no differentiation between rickettsial species
is needed, ELISA assays might be reliable diagnostic tools
for diagnosing acute cases where high antibody titres in
sera can be expected and no differentiation between rick-
ettsial species is needed. It is also a good screening tool
for high numbers of samples, when the reduction of sensi-
tivity is acceptable. The resulting seroprevalence rate then
adds up all the rickettsial species occurring in the tested
area. The micro-IFA on the other hand can be used to dif-
ferentiate several rickettsial species and to determine the
different antibody-titres, needed for example to monitor
clinical cases.Conclusion
This study reports the first results of a reliable serological
test differentiating antibodies against rickettsial SFG spe-
cies in dogs in Germany. The micro-IFA is a suitable tool
for dogs to differentiate antibodies of the SFG Rickettsiae.
Dogs are able to produce antibodies against SFG-
Rickettsiae. The results reflect the natural exposure of
dogs in Germany and could be related to the known infec-
tion rates in ticks. When compared to the micro-IFA the
ELISA of the previous study showed acceptable sensitivity
and specificity making both tests suitable for diagnostic
purposes. For epidemiological studies the IFA should be
preferred due to its higher sensitivity and specificity.Competing interests
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